CardioKinetix closes $23M tranche in $48M Series E round
February 28, 2013 by Brad Perriello
Medical device company CardioKinetix closed the 2nd, $23 million tranche of the $48 million Series E funding round for its Parachute ventricular partitioning device.
CardioKinetix said it's raised $48 million in its Series E round with the closure of a 2nd tranche worth $23 million and plans to use the proceeds to further its Parachute ventricular partitioning device, which is in a pivotal trial.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
Navigation
NEWS
Diabetes: Abbott's glucose monitor software glitch gets FDA's highest-risk recall
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
Weight loss: GI Dynamics' U.S. clinical trial taxes its coffers
Weight-loss devices maker GI Dynamics tells investors today that the company may seek new funding as...
Medtronic touts European win for Export Advance aspiration catheter
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent...
Covidien restates Q2 financials ahead of pharma spinout | Wall Street Beat
Covidien restates its financial results for its fiscal 2nd quarter ahead of the spinout of its...
Can the FDA keep its user fee promises amid sequester?
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from...
